 |
|
 |
- December 1, 2008 |
|
|
Welcome to the #1 online source of information for Diabetes Specialists! An international online community of more than 10,000 Diabetes Specialists.
CME on Diabetes is a website built to transmit top-level CME conferences given by international experts in endocrinology, insulin resistance, prediabetes, metabolic syndrome and type 2 diabetes. More than 2.6 million slides have been viewed since the website launch. Thank you for your continued support and commitment!
|
|
|
| Presentation |
|
"Obesity Management Part III - Pharmacotherapy"Dr. Trisha O'Moore-Sullivan (biography)
English - 2005-09-11 - 15 minutes
|
 | (14 slides) |
Summary :
Pharmacotherapies for obesity are currently few in number and costly. They might possibly be more cost-effective if used for weight maintenance, and should always be seen as adjuncts to calorie restriction and lifestyle therapy, says Dr. O'Moore-Sullivan.
Commonly used agents are orlistat, which inhibits the absorption of dietary fat, and sibutramine, a noradrenaline-serotonin reuptake inhibitor. The cannabinoid receptor 1 antagonists are a new class of agents, and one of these, rimonabant, was recently reported to cause significant weight loss and to improve cardiovascular risk factors (1).
Copyright © 2005 E-MedHosting.com Inc.
Learning objectives :
After viewing this presentation the participant will be able to discuss:
- Targets for pharmacotherapy of obesity
- Commonly used agents, their mechanisms of action and effects
Bibliographic references :
1. ProfLuc F Van Gaal, Aila M Rissanen, André J Scheen, Olivier Ziegler, Stephan Rössner and for the RIO-Europe Study Group
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study The Lancet, Volume 365, Issue 9468, 16 April 2005-22 April 2005, Pages 1389-1397.
|
|
|
|
|
|
| Search our website |
 |
| |
Would you like to know more about insulin resistance? Are you looking for information pertaining to Type 2 Diabetes? You can find what you are looking for in over 2000 references available on CMEonDiabetes. |
| |
|
|
| Social |
|
| |
Let others know about this presentation.
|
|
|
|
